Medication info

Wisubi Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Farmgen Science Co., Ltd.
Appearance
Round white film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201505021 · Approved 2015.07.23

This product's status changed to Expired on 2025.07.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers and gastritis); prevention of Mendelson syndrome before anesthesia
Who takes it
Adults
Adult dose
Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for combination therapy to prevent gastric or duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and other conditions usually heal within 8 weeks; however, the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Farmgen Science Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers and gastritis); prevention of Mendelson syndrome before anesthesia

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs
View approved original text

This medication is used for gastric diseases such as gastric and duodenal ulcers, gastritis, and gastroesophageal reflux disease. It also helps control excessive gastric acid secretion caused by Zollinger-Ellison syndrome. It is also used to prevent Mendelson syndrome when administered prior to anesthesia, and it is effective in preventing postoperative ulcers. It is utilized in the treatment of gastric and duodenal ulcers caused by the use of non-steroidal anti-inflammatory drugs, playing an important role in the treatment of various gastrointestinal disorders.

How to take

Adult dose

Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for combination therapy to prevent gastric or duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and other conditions usually heal within 8 weeks; however, the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets on the night before surgery.

Precautions

This medication should not be used by patients undergoing dialysis or those who have experienced allergic reactions to this medication or its components. This medication is not recommended for patients with a history of acute porphyria, and caution is advised for patients with poor kidney function or those who have undergone upper gastrointestinal surgery. Women who are pregnant or may become pregnant, premature infants, and newborns, as well as patients on a potassium-restricted diet, should avoid using this medication. Patients with liver dysfunction or a history of drug allergies, elderly patients, and those with a history of kidney disorders should use this medication cautiously. Patients taking non-steroidal anti-inflammatory drugs should be particularly careful, and since this medication can mask symptoms of gastric cancer, it is important to confirm malignancy in patients with gastric ulcers or newly occurring dyspeptic symptoms over middle age before treatment. Patients with gastric or duodenal ulcers infected with Helicobacter pylori should undergo eradication therapy. Severely ill patients being treated in intensive care units, patients with hypophosphatemia, and those with swallowing difficulties should also exercise caution when using this medication. This medication can rarely cause shock or severe allergic reactions; therefore, if symptoms arise, administration should be immediately discontinued, and appropriate treatment should be received. Various side effects such as decreased blood cell counts, liver dysfunction, arrhythmias, gastrointestinal symptoms, neuropsychiatric symptoms, myalgia, skin rashes have been reported, so if unusual symptoms occur, immediate consultation with a doctor is necessary. Long-term use is not recommended, and if there is no therapeutic effect, switching to another medication is advised. Elderly patients or those with chronic lung disease, diabetes, or weakened immune systems may have an increased risk of pneumonia when taking this medication, so caution is needed. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so if you are taking other medications, be sure to inform your healthcare provider. It is safer for women who are pregnant or breastfeeding to avoid using this medication, and safety in children has not been established, so administration is not recommended. In case of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, and blood dialysis can be performed if needed. This medication reduces gastric acid secretion, which can promote bacterial growth in the gastrointestinal tract, so regular eye examinations may be needed with long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 51 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • generalized weakness
  • lethargy
  • subcutaneous hemorrhage
  • submucosal hemorrhage
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsion
  • agitation
  • insomnia
  • headache
  • sensation of heaviness in the head
  • somatic symptoms
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movements
  • consciousness disorders
  • myoclonic cramps
  • gynecomastia
  • hyperprolactinemia
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • stomatitis
  • pruritus
  • tongue discoloration
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, ideally at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Round white film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.